Lindsay Hoover

Lindsay Hoover is a Co-Founder and Managing Partner of JLS Fund, a venture capital firm focused on investing in psychedelic and plant-based medicine technologies.12 Here are some key details about her background and work:

Professional Experience

Lindsay Hoover has over 20 years of experience in finance, including investment banking, strategic advisory, and consulting.3 She co-founded JLS Fund in 2019 to invest in the emerging psychedelics industry.4

JLS Fund Focus

JLS Fund invests in:

• Drug development and delivery technologies
• Supporting and enhancing software and technologies
• Related consumer products and services

The fund focuses on the intersection of science, technology, and neurology, leveraging the potential of plant-based and psychedelic medicines to address mental health and wellness.12

Industry Involvement

Lindsay Hoover is actively involved in the psychedelics industry:

• She frequently speaks at conferences and events related to psychedelics and mental health investments.23
• Hoover has moderated panels on topics like "Mental & Behavioral Health" and "Consolidation in the Psychedelics Industry".2
• She contributes to discussions on differentiating investment opportunities between private and public companies in the psychedelics space.2

Recent Activity

In October 2022, Lindsay Hoover shared news about a JLS Fund I portfolio company, Gilgamesh, securing a "$2B next-gen neuro deal" with a pharmaceutical company.5

Lindsay Hoover's work with JLS Fund positions her as a key figure in the emerging psychedelics investment landscape, focusing on the potential of these technologies to address mental health challenges and enhance wellness.